1[1]Eliting LS, Khardori N,Bodey GP,et al. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factor[J]. Infect Control Hosp Epidemiol, 1990,11:134-138.
2[2]Fujita J, Yamadori I, Xu G, et al. Clinical feature of Stenotrophomonas maltophilia pneumonia in immunocompromised patients[J]. Respir Med, 1996,90:35-38.
3[3]Schable B, Villarino ME, Favero MS, et al. Application of multilocus enzyme electrophoresis to epidemiologic investigation of Xanthomonas maltophilia[J]. Infect Control Hosp Epidemiol,1991,12:163-167.
4[4]Laing F, Ramotar K, Road RP, et al. Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment[J]. J Clin Microbiol,1995,33(3):531.
5[5]Muder RR, Harris AP, Muller S, et al. Bacteremia due to Xanthomonas maltophilia: a prospective multicenter study of 91 episodes[J]. Clin Infect Dis,1996,22:508.
6[6]Mett H, Rosta S, Schacher B, et al. Outer member permeability and β-lactamase content in Pseudomonas clinical isolates and laboratory mutants[J]. Rev Infect Dis,1988,10:765-769.
4National Committee for clinical Laboratory Standards: Performance Standard for antimicrobial disc susceptibility testing-seventeen informational supplement M 100-S17, Wayne, Pa, USA ;2007:32-36.
5SENOL E. Srenotrophomonas malphilia: the significance and the role as a nosocimial pathogen [ J ]. J Hosp Infect,2004,57 ( 11 ) :1-7.
